Search

everythinglearnresearchcommunity

for

Search:↓

Newborns with the common rash Erythema Toxicum have many active mast cells in their skin, but these cells don't produce the LL-37 peptide.

Deleting the MAD2L1 gene is tolerated in certain mouse cancer models.

CTHRC1 helps hair grow back, and plantar dermis mixture boosts it.

Nonimmunogenic forms of keratins K71 and K31 can delay and prevent alopecia areata.

Dandruff is linked to increased T cells and weakened immune protection in hair follicles.

Thymus transplantation successfully restored immune function in infants with FOXN1 deficiency.

People with acne have more CD4+ immune cells in their skin than healthy people.

Notch1 helps skin heal by attracting cells that aid repair.

A man developed temporary hair loss after taking a cancer drug, which might indicate a better treatment response.

A specific immune response helps control mite populations on the skin, maintaining healthy hair follicles.

Everyone has an immune response to PPD, but reactions differ, causing tolerance, mild inflammation, or allergy.

Higher CRHR1 levels in AA patients lead to increased inflammation.

PI3Kδ inhibition may effectively treat cutaneous chronic graft-versus-host disease.

HPV16-transformed cells can change human skin cell properties, aiding tumor growth.

IL-1β inhibits human hair follicle growth.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Hair follicle stem cells help heal wounds by turning certain immune cells into ones that reduce inflammation.

IL-2 treatment causes skin eruptions and other reversible side effects, and may play a role in psoriasis.

TCDD changes skin cell growth and keratin production in mice.

High-dose interferon is effective for chronic hepatitis C but often causes flu-like symptoms.

Regulatory T cells help hair growth by using the Cxcr4-Cxcl12 pathway.

Blocking CCR5 can prevent and improve hair loss in alopecia areata.

Tislelizumab can cause cutaneous lupus erythematosus.

Deleting Snai2 and Snai3 causes fatal autoimmunity.

CD1d expression in scalp skin and hair follicles changes with the hair cycle and may help protect against microbes.

Inhibiting TYK2 can restore hair growth in alopecia areata.

M1 homeopathic complex may help slow melanoma cell growth.

Higher PD-1 levels mean fewer CD8+ T cells in alopecia areata hair follicles.

Ruxolitinib may effectively treat APS-1 by reducing harmful immune responses.